DiMeglioL.A., WhiteK.E., EconsM.J.Disorders of phosphate metabolism. Endocrinol Metab Clin North Am2000; 29: 591–609.
2.
BieleszaB., KlaushoferbK., OberbauerR.Renal phosphate loss in hereditary and acquired disorders of bone mineralization. Bone2004; 35: 1229–39.
3.
ShimadaT., MutoT., UrakawaI.. Mutant FGF-23 Responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology143(8): 3179–82.
4.
The ADHR Consortium.Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nature Genet2000; 26: 345–8.
5.
Lorenz-DepiereuxB., BastepeM., Benet-Page'sA.. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nature Genet2006; 38: 1248–50.
6.
Lorenz-DepiereuxB., SchnabelD., TiosanoD., HausleG., StromT.M.Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am J Hum Genet2010; 86, 267–72.
7.
BergwitzC., RoslinN.M., TiederM.. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet2006; 78: 179–92.
8.
MagenD., BergerL., CoadyM.J.. A loss-of-function mutation in NaPi-IIa and renal Fanconi's syndrome. N Engl J Med2010; 362: 1102–09.
9.
LloydS.E., PearceS.H., FisherS.E.. A common molecular basis for three inherited kidney stone diseases. Nature1996; 379: 445–9.
10.
HoopesR.R., ShrimptonA.E., KnohlS.J.. Dent Disease with mutations in OCRL1. Am J Hum Genet2005; 76: 260–7.
11.
Lichter-KoneckiU., BromanK.W., BlauE.B., KoneckiD.S.Genetic and physical mapping of the locus for autosomal dominant renal Fanconi syndrome, on chromosome 15q15.3. Am J Hum Genet2001; 68: 264–8.
12.
KarimZ., GérardB., BakouhN.. NHERF1 mutations and responsiveness of renal parathyroid hormone. N Engl J Med2008; 359: 1128–35.
13.
MalloyP.J., HochbergZ., TosanoD., PikeJ.W., HughesM.R., FeldmanD.The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families. J Clin Invest1990; 86: 2071–9.
14.
ChengJ. B., LevineM. A., BellN. H., MangelsdorfD. J., RussellD. W.Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Nat Acad Sci2004; 101: 7711–5.
15.
HughesM.R., MalloyP.J., KiebackD.G.. Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science1988; 242: 1702–05.
16.
PrièD., FrielanderG.Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system. Clin J Am Soc Nephrol2010; 5: 1717–22.
17.
MakrasP., NeveenA., KantS.G., PapapoulosS.E.Normal Growth and Muscle Dysfunction in X-Linked Hypophosphatemic Rickets Associated with a Novel Mutation in the PHEX Gene. J Clin Endocrinol Metab2008; 93: 1386–9.
18.
MäkitieO., DoriaA., KoohS.W., ColeW.G., DanemanA., SochettE.Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab2003; 88: 3591–7.
19.
AlonU., NewsomeH.Jr., ChanJ.C.Hyperparathyroidism in patients with X-linked dominant hypophosphatemic rickets - application of the calcium infusion test as an indicator for parathyroidectomy. Int J Pediatr Nephrol1984; 5: 39–43.
20.
MäkitieO., KoohS.W., SochettE.Prolonged high-dose phosphate treatment: a risk factor for tertiary hyperparathyroidism in X-linked hypophosphatemic rickets. Clin Endocrinol (Oxf)2003; 58: 163–8.
21.
ThomasW.C., FryR.M.Parathyroid adenomas in chronic rickets. Am J Med1970; 49: 404–07.
MarieP.J., GlorieuxF.H.Relation between hypomineralized periosteocytic lesions and bone mineralization in vitamin D-resistant rickets. Calcif Tissue Int1983; 35: 443.
24.
VaisbichM.H., KochV.H.Hypophosphatemic rickets: results of a long-term follow-up. Pediatr Nephrol2006; 21: 230–4.
25.
Blydt-HansenT.D., TenenhouseH.S., GoodyerP.PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia. Pediatr Nephrol1999; 13: 607–11.
26.
AlonU.S., Levy-OlomuckiR., MooreW.V., StubbsJ., QuarlesL.D.Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets. Clin J Am Soc Nephrol2008; 3: 658–64.
27.
MeolaM., PetrucciI., BarsottiG.Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism. Nephrol Dial Transplant2009; 24: 982–9.
28.
PatriquinH., & RobitailleP.Renal calcium deposition in children: sonographic demonstration of the Anderson-Carr progression. Am J Roentgenology1986; 146: 1253–6.
